Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AV650-018: Tolperisone for spasticity associated with multiple sclerosis
2007-001031-63Phase 2Terminated
- Sponsor
- Avigen
- Start
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Muscle spasm and multiple sclerosis (MS) comparing AV650 / tolperisone arm with Placebo then AV650 arm (2 arms). Primary endpoints: Long-term safety and tolerability of AV650 and Preliminary efficacy of AV650 vs placebo. Started Aug 2007; status: terminated.
02
Drugs
tolperisone
03
Conditions
Muscle spasmmultiple sclerosis (MS)
Beyond the preview
Go deeper on 2007-001031-63.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001031-63.